Advisor Group Holdings, Inc. Biogen Inc. Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 11,130 shares of BIIB stock, worth $1.79 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

11,130

Previous 13,565 17.95%

Holding current value

$1.79 Million

Previous $3.14 Million 31.39%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$189.07 - $236.8 $460,385 - $576,608	-2,435 Reduced 17.95%	11,130 $2.16 Million
Q2 2024 Aug 13, 2024	SELL	$190.52 - $236.72 $522,405 - $649,086	-2,742 Reduced 16.81%	13,565 $3.14 Million
Q1 2024 May 10, 2024	SELL	$212.02 - $267.71 $514,360 - $649,464	-2,426 Reduced 12.95%	16,307 $3.52 Million
Q4 2023 Feb 12, 2024	SELL	$222.59 - $267.94 $3.57 Million - $4.29 Million	-16,020 Reduced 46.1%	18,733 $4.85 Million
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $2.47 Million - $2.79 Million	9,765 Added 39.08%	34,753 $8.93 Million
Q2 2023 Aug 21, 2023	SELL	$275.25 - $318.06 $2.5 Million - $2.89 Million	-9,084 Reduced 26.66%	24,988 $7.12 Million
Q2 2023 Aug 10, 2023	BUY	$275.25 - $318.06 $2.26 Million - $2.61 Million	8,203 Added 31.71%	34,072 $9.71 Million
Q1 2023 May 12, 2023	SELL	$256.56 - $292.34 $1.23 Million - $1.4 Million	-4,775 Reduced 15.58%	25,869 $7.19 Million
Q4 2022 Feb 10, 2023	BUY	$252.44 - $306.72 $1.43 Million - $1.74 Million	5,677 Added 22.74%	30,644 $8.49 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $405,344 - $558,933	2,082 Added 9.1%	24,967 $6.67 Million
Q2 2022 Aug 10, 2022	BUY	$187.54 - $223.02 $127,339 - $151,430	679 Added 3.06%	22,885 $4.68 Million
Q1 2022 May 04, 2022	SELL	$193.77 - $244.14 $2.18 Million - $2.75 Million	-11,267 Reduced 33.66%	22,206 $4.81 Million
Q3 2021 Nov 05, 2021	SELL	$282.99 - $369.05 $839,631 - $1.09 Million	-2,967 Reduced 8.14%	33,473 $9.47 Million
Q2 2021 Aug 02, 2021	SELL	$259.0 - $414.71 $686,609 - $1.1 Million	-2,651 Reduced 6.78%	36,440 $12.6 Million
Q1 2021 May 13, 2021	BUY	$242.95 - $284.63 $917,136 - $1.07 Million	3,775 Added 10.69%	39,091 $10.9 Million
Q4 2020 Feb 10, 2021	BUY	$236.26 - $355.63 $269,100 - $405,062	1,139 Added 3.33%	35,316 $8.65 Million
Q3 2020 Nov 12, 2020	BUY	$264.77 - $305.71 $1.38 Million - $1.59 Million	5,194 Added 17.92%	34,177 $9.66 Million
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $12.3 Million - $16.2 Million	-47,367 Reduced 62.04%	28,983 $7.76 Million
Q1 2020 May 18, 2020	BUY	$268.85 - $341.04 $20.5 Million - $26 Million	76,350 New	76,350 $10 Million

Others Institutions Holding BIIB

# of Institutions

1,038

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $23.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Biogen Inc. Transaction History